Immunogenicity and fecal poliovirus excretion in sequential use of inactivated and oral poliovirus vaccines

Journal of the Formosan Medical Association

Volumn 100, Issue 8, 2001, Pages 513-518

  Lu, C Y ^a   Kao, C L ^a   Lee, C Y ^a   Lee, P I ^a   Huang, L M ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Poliovirus; Sequential vaccination; Taiwan; Vaccine

Indexed keywords

INACTIVATED VIRUS VACCINE; LIVE VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

AGE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FECES; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOGENICITY; INFANT; INJECTION PAIN; INOCULATION; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; SAMPLING; SIDE EFFECT; SYSTEMIC DISEASE; TAIWAN; VACCINATION; VIRUS EXCRETION; VIRUS IMMUNITY; VIRUS ISOLATION; VIRUS SHEDDING; VIRUS STRAIN;

ANTIBODIES, VIRAL; FECES; FEMALE; HUMANS; INFANT; MALE; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; VACCINATION;

EID: 0034772567     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Global Eradication of Poliomyelitis by the Year 2000: Resolution of the 41st World Health Assembly
2. CDC: Certification of poliomyelitis eradication - Western Pacific Region
3. Risk of vaccine-associated poliomyelitis in Latin America, 1989-1991
4. Interrupting the transmission of wild polioviruses with vaccines: Immunologic considerations
5. Oral poliovirus vaccine in tropical Africa: Greater impact on incidence of paralytic disease than expected from coverage surveys and seroconversion rates
6. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine for routine use in the United States
7. Impact of the sequential poliovirus immunization schedule: A demonstration
8. Sequential and combined use of inactivated and oral poliovirus vaccines: Dolj District, Romania, 1992-1994
9. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman
10. Inactivated poliovirus vaccine alone or sequential inactivated and oral poliovirus vaccine in two-, four- and six-month-old infants with combination Haemophilus influenzae type b/hepatitis B vaccine
11. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries
12. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference
13. Progress toward poliomyelitis eradication - South-East Asia region, 1998-1999
14. Molecular variation of Type 1 vaccine-related wild polioviruses during replication in humans
15. Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome
16. Immunogenicity of oral poliovirus vaccine in Taiwan
17. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: Systemic and local immune responses
18. To conquer poliomyelitis forever
19. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Polio Vaccine Group
20. Vaccine-associated paralytic poliomyelitis
21. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease
22. Comparative study of poliovirus excretion after vaccination of infants with two oral polio vaccines prepared on Vero cells or on primary monkey kidney cells
23. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine